588
Views
0
CrossRef citations to date
0
Altmetric
Brief Report

Treatment of patients with evidence of mast cell-mediated itch in the absence of hives with omalizumab

&
Article: 2371545 | Received 31 May 2024, Accepted 18 Jun 2024, Published online: 07 Jul 2024

References

  • Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022;77(3):1–4. doi:10.1111/all.15090.
  • Kolkhir P, Giménez-Arnau AM, Kulthanan K, et al. Urticaria. Nat Rev Dis Primers. 2022;8(1):61. doi:10.1038/s41572-022-00389-z.
  • Asero R, Ferrer M, Kocaturk E, et al. Chronic spontaneous Urticaria: the role and relevance of autoreactivity, autoimmunity, and autoallergy. J Allergy Clin Immunol Pract. 2023;11(8):2302–2308. doi:10.1016/j.jaip.2023.02.022.
  • Kolkhir P, Muñoz M, Asero R, et al. Autoimmune chronic spontaneous Urticaria. J Allergy Clin Immunol. 2022;149(6):1819–1831. doi:10.1016/j.jaci.2022.04.010.
  • Biagtan MJ, Viswanathan RK, Mathur SK. The chronic Urticaria index as a predictor of responsiveness to therapy. J Allergy Clin Immunol. 2011;127(2):AB104–AB104. doi:10.1016/j.jaci.2010.12.417.